In xenograft mice studies, it was found that anti-ERVK Env monoclonal antibodies were able to inhibit the growth of and induce apoptosis in tumor cells (Wang-Johanning et al., 2012; Cegolon et al., 2013). This evidence concerns the gene ERVW-1 and neoplasm.